haloalkane

(redirected from Hydrofluoroalkane)
Also found in: Dictionary, Thesaurus.

haloalkane

[¦ha·lō¦al‚kān]
(organic chemistry)
Halogenated aliphatic hydrocarbon.
Mentioned in ?
References in periodicals archive ?
A Post-hoc Responder Analysis of Improvement in Symptoms Following Treatment with Ciclesonide Hydrofluoroalkane Nasal Aerosol in Patients with Seasonal and Perennial Allergic Rhinitis (Poster #667)
A Scintigraphy Study Evaluating the Nasal and Pulmonary Deposition of a Radiolabeled Solution of Ciclesonide Hydrofluoroalkane Nasal Aerosol and a Radiolabeled Suspension of Ciclesonide Aqueous Nasal Spray in Healthy Subjects (Poster #339) In a Phase I, open-label, two-period, non-randomized scintigraphy study, healthy volunteer patients (N=10) 18-65 years of age received a single dose of a radiolabeled solution of CIC-HFA 148 mcg via a metered dose inhaler, a washout period of 72 hours, followed by a single dose of a radiolabeled suspension of CIC-AQ (aqueous) 200 mcg via an aqueous nasal pump spray.
Food and Drug Administration (FDA) has approved the sNDA (Supplemental New Drug Application) for AEROSPAN([R] )(flunisolide HFA, 80 mcg) Inhalation Aerosol, a hydrofluoroalkane (HFA) orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients 6 years of age and older.
This includes our production of non-ozone-depleting hydrofluoroalkane (HFA) gas propelled pharmaceutical products, enhanced single and combination drug inhalation-therapy treatments, and hydrocarbon foam dermatology/topical formulations.
ZETONNA uses an environmentally friendly hydrofluoroalkane (HFA) propellant and features an easy-to-read, built-in dose indicator so patients can track when their prescriptions should be refilled.
PT003 is a proprietary fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist (LABA) delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA MDI).
beclomethasone (Qvar) Formulation with hydrofluoroalkane propellant.
ZETONNA Nasal Aerosol uses an environmentally-friendly hydrofluoroalkane (HFA) propellant and features an easy-to-read, built-in dose indicator so patients can track when their prescriptions should be refilled.
PT003 (GFF MDI) is an investigational inhaled combination bronchodilator product comprising glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA), and formoterol (FF), a well-known, established, long-acting beta-2 agonist (LABA), delivered together for the first time via a hydrofluoroalkane metered dose inhaler (HFA MDI), using a proprietary cosuspension formulation approach.
A major advantage of inhaled steroids such as the recently approved QVAR--a metered-dose inhaler containing beclomethasone dipropionate with a hydrofluoroalkane (HFA) propellant rather than a chiorofluorocarbon propellant-is that the propellant sends smaller particles of medication into the lungs than traditional aerosol inhalers ever could.
PT003 is a proprietary fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA), and formoterol fumarate (FF), an established, long-acting beta-2 agonist (LABA) delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA MDI).
The smaller particles achieved with the new hydrofluoroalkane (HFA) vehicles allow the inhaled steroid to penetrate more deeply into the alveoli.